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Abstract
Background: Determinants of exhaled nitric oxide (FeNO) need to be understood better to
maximize the value of FeNO measurement in clinical practice and research. Our aim was to identify
significant predictors of FeNO in an initial cross-sectional survey of southern California
schoolchildren, part of a larger longitudinal study of asthma incidence.
Methods: During one school year, we measured FeNO at 100 ml/sec flow, using a validated offline
technique, in 2568 children of age 7–10 yr. We estimated online (50 ml/sec flow) FeNO using a
prediction equation from a separate smaller study with adjustment for offline measurement
artifacts, and analyzed its relationship to clinical and demographic characteristics.
Results: FeNO was lognormally distributed with geometric means ranging from 11 ppb in children
without atopy or asthma to 16 ppb in children with allergic asthma. Although effects of atopy and
asthma were highly significant, ranges of FeNO for children with and without those conditions
overlapped substantially. FeNO was significantly higher in subjects aged > 9, compared to younger
subjects. Asian-American boys showed significantly higher FeNO than children of all other sex/
ethnic groups; Hispanics and African-Americans of both sexes averaged slightly higher than non-
Hispanic whites. Increasing height-for-age had no significant effect, but increasing weight-for-height
was associated with decreasing FeNO.
Conclusion:  FeNO measured offline is a useful biomarker for airway inflammation in large
population-based studies. Further investigation of age, ethnicity, body-size, and genetic influences
is needed, since they may contribute to substantial variation in FeNO.
Introduction
The fractional concentration of exhaled nitric oxide
(FeNO) is associated with the degree of airway inflamma-
tion and oxidative/nitrosative stress [1-5]. Measurement
of FeNO has proven useful in clinical diagnosis and man-
agement of asthma [1-8] and in epidemiologic assessment
of asthma and other respiratory diseases in children and
adults [9-13]. We are conducting a longitudinal study of
FeNO and its relationship to new-onset asthma in a large
population-based sample of children participating in the
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Children's Health Study (CHS), an ongoing prospective
cohort study of environmental and genetic determinants
of respiratory health in southern California children [14-
17]. We began annual FeNO measurements during the
2004–05 school year, testing more than 2500 children,
most of whom were 8–9 years old and in grade 3, at
schools in 13 communities representing a wide range of
air quality. We used a validated offline technique [18-20]
involving breath collection at schools with expiratory flow
controlled near 100 ml/sec, refrigerated storage/transport
of samples, and delayed analysis at a central laboratory.
Using a calibration equation, the offline results were
adjusted to equivalence with online FeNO measurements
at the standard 50 ml/sec expiratory flow rate. This paper
presents cross-sectional analyses of the initial year's data,
intended to describe separate and interactive effects of
allergy, asthma, and demographic factors on FeNO in this
large, community-based population of children.
Methods
Study Population
Subjects were drawn from a CHS cohort of public-school
students in 13 Southern California communities with dif-
ferent levels and types of air pollution, originally recruited
in the 2002–3 school year when they were in kindergarten
or grade 1. Informed assent was sought from each child,
and informed consent from a parent or guardian, for
FeNO testing. The protocol was reviewed and approved by
the University of Southern California Institutional Review
Board. Consent was obtained and testing was performed
successfully on 2792 subjects out of 3544 available cohort
members. As described in Additional file 1, some breath
samples were rejected because of delayed analysis after an
instrument failure, or anomalously high concentrations
thought to result from outdoor light exposure; and a few
subjects were excluded because of missing clinical or
height/weight information. We attempted to test all par-
ticipants without asthma and a sample of those with
asthma. Thus, data were analyzable for 2568 subjects
(92% of those tested, 72% of available cohort members).
Table 1 presents descriptive data for this population.
Subject Characterization
Questionnaires, distributed to children at school and
completed by parents, were used to determine children's
demographic and allergy/asthma characteristics [14,16].
Using questionnaire responses, each child was assigned to
one of the following clinical groups for statistical compar-
ison: healthy (no report of asthma or allergy in question-
naires from 2002 through 2004), respiratory allergy
without asthma, asthma without respiratory allergy, or
asthma with respiratory allergy. (Children with reports of
Table 1: Selected Demographic Characteristics for 2568 Children with Valid FeNO measurements, Children's Health Study
Girls (N = 1316) Boys (N = 1252)
Counts Number % Number %
Race/ethnicity
Non-Hispanic White 452 34.4 440 35.1
Hispanic 731 55.6 688 55.0
African-American 27 2.0 22 1.8
Asian-American 40 3.0 40 3.2
Other/Unknown 66 5.0 62 4.9
Age
< 8 yr 447 34.0 372 29.7
8–9 yr 644 48.9 592 47.3
>= 9 yr 225 17.1 288 23.0
Clinical Group
Healthy 613 46.6 557 44.5
Allergy Only 608 46.2 562 44.9
A s t h m a  O n l y 2 01 . 52 62 . 1
Allergy + Asthma 75 5.7 107 8.5
Summary Statistics Mean ± SD Range Mean ± SD Range
Age, yr 8.3 ± 0.6 6.4 – 10.4 8.4 ± 0.7 7.0 – 10.5
Height, cm 129 ± 7 108 – 157 131 ± 7 113 – 158
Weight, kg 30 ± 8 17 – 70 32 ± 8 19 – 72
Residual height-for-age, cm[a] 0 ± 6 -18 – +24 0 ± 6 -17 – +22
Residual weight-for-height, kg[b] 0 ± 5 -21 – +28 0 ± 6 -17 – +35
[a] Observed height minus predicted height for subject's age; predicted values determined from cubic polynomial fit to data for all subjects of the 
same sex in this population (see text).
[b] Observed weight minus predicted weight for subject's height; predicted values determined as described in note [a].Respiratory Research 2009, 10:28 http://respiratory-research.com/content/10/1/28
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wheeze but no asthma or allergy, initially considered as a
separate group, were ultimately included in the healthy
group because their FeNO showed nonsignificant differ-
ences from other healthy subjects.) Children were classi-
fied as having asthma based on parents' report of a
physician diagnosis of asthma. In an earlier validation
study on a subsample, 95% of such reports were corrobo-
rated by medical record review [21]. In analyses to explore
effects of asthma severity and medication usage, children
with evidence of asthma were assigned to one of the fol-
lowing groups: 1) reported asthma medication use with-
out an asthma diagnosis, 2) physician diagnosis of
asthma but no medication use, 3) active asthma with res-
cue medication only (i.e. as-needed bronchodilators), 4)
active asthma with controller medication (i.e. regular
long-acting bronchodilators, corticosteroids, or leukot-
riene inhibitors). Subjects were also classified according
to their age on the day of testing. Because a preliminary
analysis indicated that FeNO variation was not linear with
age, age strata were defined with cutpoints at 8.00 and
9.00 yr. (An alternative analysis by quartiles of age gave
similar results.) Height and weight were measured on the
day of testing and were compared with growth charts from
the Centers for Disease Control (CDC) [22]. Weight-for-
height distribution was substantially above CDC norms.
Therefore, we calculated predictions of weight-for-height
and height-for-age for our population, emulating the
CDC approach. We used least-squares regression to deter-
mine cubic polynomial prediction equations for each var-
iable, separately for each sex but pooling all ethnic groups.
We then calculated residual (observed minus predicted)
height-for-age and weight-for-height for each subject, and
used these residuals as predictor variables in statistical
modeling of FeNO. Residuals (summary statistics in Table
1) correlated weakly with each other or with age (r
between -0.1 and +0.1), unlike height and weight per se (r
between +0.3 and +0.7), thus allowing more stable model
estimates of body size effects on FeNO independent of
age.
Sample Collection, Transport, and Analysis
Exhaled breath collection was performed at schools, usu-
ally from midmorning to noon to avoid traffic-related
peaks of ambient NO and possible effects of recent eating
on FeNO. Each community was visited at least twice in
different seasons, to minimize confounding of location
and season effects. Health status at testing was evaluated
by a brief questionnaire; subjects with symptoms of acute
respiratory infection within the past 3 days were excluded
or rescheduled. The methodology for offline measure-
ment of FeNO was validated by a small-scale a priori com-
parison against conventional online measurements [18],
and by a larger-scale post hoc comparison study [19,20]
described later. Breath was collected in aluminized Mylar
bags using commercial breath sampling kits (Sievers Divi-
sion, GE Analytical Instruments, Boulder, Colorado,
USA), following the manufacturer's instructions based on
American Thoracic Society (ATS) recommendations [1].
The target expiratory flow and pressure were 100 ml/sec
and 19 cmH2O respectively. The subject took 2–3 initial
deep breaths through the kit's NO scrubber – which was
less than 100% effective [19,20] – followed by a near-
vital-capacity breath and immediate controlled exhalation
through the sampling kit. Deadspace air was discarded for
approximately 3 sec, then 0.5–1 L of exhalate was col-
lected in the bag. Bag samples of ambient air, collected
similarly through the breath sampling kit by removing the
NO scrubber and drawing the sample with a syringe, were
used to estimate each subject's ambient NO exposure at
the time of testing. All bag samples were stored in coolers
and transported to a central laboratory, where NO was
measured using a standard chemiluminescent analyzer
system (Sievers Division). The resulting offline FeNO data
were converted to estimates of "standard" FeNO as would
be measured online at 50 ml/sec expiratory flow [3], using
a statistical model determined in the post hoc comparison
study [19,20], which involved 362 children (including
309 from this population) measured on and off line in the
same testing session. The statistical model, described in
Additional file 1, accounted for artifacts in offline meas-
urements due to varying ambient NO concentrations and
varying lag times between breath collection and analysis.
Commercial software (SAS Institute, Cary, NC) was used
for data quality checking and subsequent analysis. After
exclusion of samples that developed problems after col-
lection and subjects with incomplete demographic or
clinical information (see Additional file 1), 2,568 subjects
had usable data. Predicted online FeNO (50 ml/sec) was
tested for effects of asthma status and demographic char-
acteristics (sex, ethnic group, age, community of resi-
dence) using regression models fit with SAS procedure
MIXED. Previously mentioned grouping variables and
community of residence were treated as fixed factors. Ini-
tially, main effects of each factor were tested; subse-
quently, two-way interactions between grouping factors
were tested one at a time, by adding the interaction term
to the original main-effects model. To verify that signifi-
cant differences were not artifacts of the process used to
predict online FeNO, the same analytical model was
applied to raw offline FeNO measurements (originally
measured values, not adjusted for any technical artifacts).
Analyses were performed on log-transformed FeNO data
to obtain more nearly normal distributions. Effects with
2-sided P < 0.05 were considered statistically significant.
Results
Overview
Table 1 provides a statistical description of the 2,568 sub-
jects with analyzable data. They generally resembled theRespiratory Research 2009, 10:28 http://respiratory-research.com/content/10/1/28
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entire tested population of 2,792, although nonwhite and
Hispanic subjects were somewhat underrepresented (see
Additional file 1). Table 2 shows key results from regres-
sion analysis of predicted conventional online FeNO.
Additional file 1 provides more detailed results. Table 3
shows key results from the analysis of raw offline FeNO
data. Proportional changes between groups were similar,
and the pattern of significant group differences was iden-
tical, with raw offline and predicted online data. Thus,
group differences reflect underlying biology and are not
artifacts of the adjustment or estimation process. FeNO
varied appreciably by ethnicity, age group, asthma status,
and respiratory allergy status. Figure 1 illustrates the distri-
bution of predicted online FeNO by clinical group. Values
diverged (mostly in the upper halves of the distributions)
but still overlapped considerably: the 75th percentile for
allergic-asthmatic subjects was similar to the 90th percen-
tiles for subjects with allergy only or asthma only, and the
95th percentile for healthy subjects. Receiver operating
characteristic (ROC) curves (not shown) were examined
to determine how well the FeNO measurement could dis-
criminate individuals with allergy or asthma from those
without these conditions. To minimize confounding by
nonclinical factors, ROC analyses were limited to non-
Hispanic white and Hispanic subjects, and performed sep-
arately for subjects below and above age 9. Areas under
ROC curves were 0.60 or less for allergy versus no allergy,
or for any asthma versus no asthma. (Area of 0.50 would
indicate no ability to detect allergy or asthma, and 1.0
would indicate correct classification of every subject.) The
ability to classify active asthma with recurrent clinically
significant wheezing, or with medication use in the past
year, was slightly better, with areas under ROC curves of
0.66 to 0.68.
Variation in FeNO by Clinical Status
Asthma/allergy groups showed highly significant (P <
0.0001) overall differences in FeNO. Asthma-without-
allergy and allergy-without-asthma groups showed
roughly similar increments relative to healthy subjects,
while children with both respiratory allergy and asthma
showed substantially larger increments. The asthma-with-
out-allergy group, considered by itself, was not signifi-
cantly different from healthy subjects, possibly because its
small size limited statistical power of the group-compari-
son test. In a model including separate and interactive
effects of allergy and asthma, both main effects were sig-
nificant (P < 0.001) but the interaction did not reach sta-
tistical significance. Again, the interaction test had low
power due to the small number of non-allergic asthmat-
ics. Other 2-way interactions of grouping factors were
nonsignificant, with the exception of sex and ethnicity,
discussed below.
To investigate the relationship of asthma activity and
medication use to FeNO, we examined geometric mean
FeNO for subgroups of physician-diagnosed asthmatic or
asthma-medication-using subjects, adjusted for nonclini-
cal factors as above. Detailed results are given in Addi-
tional file 1. Overall differences by medication status were
statistically significant (P < 0.05) but small: geometric
means were approximately 12 ppb in diagnosed asthmat-
Table 2: Geometric Mean FeNO* among Children by Demographic and Clinical Determinants of FeNO, CHS 2003–4 Subjects with 
Valid FeNO Data**
GROUP Geometric Mean FeNO
(ppb)
95% Confidence Interval of Geometric Mean P Value for Group Main Effect
Female 12.63 (11.75, 13.56) 0.69
Male (reference) 12.75 (11.88, 13.68)
Non-Hispanic White (reference) 11.56 (10.85, 12.31) <0.0001
Hispanic‡ 12.54 (11.84, 13.29)
African American 12.65 (10.58, 15.13)
Asian American‡ 16.10 (14.00, 18.53)
Other 11.12 (9.93, 12.45)
Age < 8‡ 12.15 (11.29, 13.08) <0.0001
Age 8–9‡ 12.25 (11.42, 13.13)
Age >= 9 (reference) 13.72 (12.62, 14.91)
Healthy (reference) 10.95 (10.34, 11.61) <0.0001
Allergy only‡ 12.39 (11.71, 13.10)
Asthma only 12.07 (10.09, 14.45)
Allergy + Asthma‡ 15.81 (14.33, 17.43)
* Regression Predicted Online FeNO (50 ml/sec).
** Analytical model includes main effects of sex, ethnic group, clinical group, age stratum, height-for-age, weight-for-height, and community; see 
Additional file 1 for additional results.
‡Different from reference group, P < 0.001.Respiratory Research 2009, 10:28 http://respiratory-research.com/content/10/1/28
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ics with no medication use and in medication users with
no asthma diagnosis, 13 in diagnosed asthmatics using
rescue medication only, and 17 in those using rescue plus
controller medications. Thus, in our population more
clinically persistent asthma was associated with a higher
FeNO, which was not entirely counteracted by more
intensive medication use.
Demographic Determinants of FeNO
Age and ethnic group were significantly associated with
FeNO (P < 0.0001 for either main effect). Point estimates
for both younger age strata were about 11% lower than
that for the 9 year-and-older stratum, after adjustment for
other factors. Compared to the non-Hispanic white refer-
ence group, Asian-Americans showed a relatively large sig-
nificant increase. Hispanics and African-Americans
showed smaller increases, significant in Hispanics but not
significant in African-Americans, probably because their
smaller numbers limited statistical power. Elevated FeNO
in Asian-Americans occurred primarily in boys. Figure 2
summarizes results from an analytical model including an
interactive effect of ethnic group and sex, which was sig-
nificant (P < 0.01), with a markedly larger estimated incre-
ment in Asian-American boys than girls (point estimates
81% and 7% respectively, relative to non-Hispanic whites
of the same sex). The increment was observable in healthy
and in allergic boys; asthmatics were too few for reliable
comparison.
Effect of Body Size on FeNO
Weight was associated with FeNO levels, while height was
not, after accounting for effects of age. Residual weight-
for-height (weight difference from a typical subject of the
same sex and height, without regard to age) showed a
small statistically significant (P < 0.01) negative effect,
estimated at 0.7% decrease in FeNO per kilogram. For
example, in healthy >9-year-old non-Hispanic white boys
of typical height, an increase of 20 kg above typical weight
would predict a decrease in FeNO from 12.5 to 10.8 ppb.
An alternative analysis by quartiles of residual weight-for-
height (data not shown) indicated that this effect was
present over most or all of the weight range, i.e. not driven
by a minority of overweight or underweight individuals.
Although weight-for-height was significantly higher in
Hispanics than in Non-Hispanic whites, the weight effect
did not explain those groups' significant difference in
FeNO (see Additional file 1). Too few data were available
to compare other ethnic groups in the same manner.
Discussion
Overview
This large population-based study evaluated FeNO in a
community population of schoolchildren in a region with
generally milder climate, but generally more severe air
pollution, than locations of other FeNO surveys. The
results corroborated previous findings that respiratory
allergy, asthma, Asian ancestry, and effects of maturation
tend to increase children's FeNO. New findings included
slight but significant elevation of FeNO in Hispanic rela-
tive to non-Hispanic white children, and a slight but sig-
nificant tendency for FeNO to decrease with increasing
weight in children of a given height.
Effect of Clinical Status
We found highly significant positive effects of respiratory
allergy or asthma on FeNO. Increases due to allergy and/
Table 3: Regression Results: Unadjusted Offline FeNO (100 ml/sec) by Demographic and Clinical Category, CHS 2003–4 Subjects with 
Valid FeNO Data*
GROUP Geometric Mean FeNO 95% Confidence Interval of Geometric Mean P Value for Group Main Effect
Female 8.31 (7.85, 8.80) 0.62
Male (reference) 8.39 (7.93, 8.87)
Non-Hispanic White (reference) 7.85 (7.47, 8.25) <0.0001
Hispanic‡ 8.29 (7.92, 8.68)
African American 8.31 (7.21, 9.57)
Asian American‡ 9.98 (8.93, 11.15)
Other 7.52 (6.88, 8.22)
Age < 8‡ 8.17 (7.71, 8.66) <0.0001
Age 8–9‡ 8.13 (7.69, 8.59)
Age >= 9 (reference) 8.77 (8.21, 9.36)
Healthy (reference) 7.50 (7.16, 7.85) <0.0001
Allergy only‡ 8.40 (8.03, 8.78)
Asthma only 7.83 (6.79, 9.02)
Allergy + Asthma‡ 9.86 (9.13, 10.65)
*Analytical model includes main effects of sex, ethnic group, clinical group, age stratum, height-for-age, weight-for-height, and community.
‡Different from reference group, P < 0.001.Respiratory Research 2009, 10:28 http://respiratory-research.com/content/10/1/28
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or asthma have been found in numerous earlier smaller-
scale studies of children and adults [4-10,23-26]. Levels of
FeNO were, however, not greatly elevated in our sample
of asthma cases in comparison with our healthy subjects.
The relatively small differences (compared to differences
found in many clinic-based studies) may reflect mildness
of asthma in this population-based sample, relatively
effective suppression of elevated NO by asthma medica-
tion, or misclassification of asthma status (based only on
parents' questionnaire reports). Although most question-
naire reports should be valid, as judged by medical record
review in a subsample [21], "false positive" and "false neg-
ative" asthma classifications still might be more likely
here than in a clinic-based study with uniform diagnostic
testing. If so, the FeNO difference between subjects with
and without asthma would be underestimated here. The
same would be true concerning allergy, even less clearly
definable than asthma. Subject to these limitations, the
allergy effect appeared to be equal or larger, and more sig-
nificant, than the asthma effect in this population. Point
estimates suggested that the combined effect of allergy
and asthma was more than additive, but statistical tests
did not confirm synergism. A previous population-based
survey of Canadian children mostly older than our sub-
jects, employing online FeNO testing and health ques-
tionnaires, found that mean FeNO varied by health status
in the same manner as we observed, i.e. allergy + asthma
> allergy only > asthma only > healthy [23]. In a smaller
population-based study of Finnish children, with a wider
age range than ours and with individual medical testing to
establish health status, atopy was a significant predictor of
increased FeNO, while asthma was not [26]. Thus, these
geographically and methodologically diverse population-
based studies suggest that allergy increases FeNO as does
asthma.
Typical FeNO levels in our population were slightly lower
than in the Canadian study (consistent with its older age
range), but slightly higher than in subjects of similar age
in the Finnish study. Some difference in FeNO readings
between studies may be expected, given inherent variabil-
ity of NO analyzers [27,28] and standard gases, as well as
differences in subject selection, clinical classification, and
methods of calculating summary statistics.
A potentially important finding, which is not new but
seems to have received little attention, is that an apprecia-
ble percentage of clinically healthy subjects have FeNO
levels in the range usually associated with poorly control-
led asthma. For our Hispanic and non-Hispanic white
subjects reported to be free from allergy or asthma, the
95th and 99th percentiles of FeNO were near 30 and 60
ppb respectively, and the highest values were near 100
ppb. We cannot entirely rule out the possibility that some
of these high values resulted from artifacts, similar to the
known incidents described in Additional file 1. Even so,
our overall results in healthy subjects are consistent with
those found by Kovesi et al. [24] using state-of-the-art
online testing equipment. In their survey, about 2% of
healthy non-Hispanic white subjects aged 9–12 exceeded
50 ppb ([24] Figure 1). Further investigation is warranted
to determine whether these atypically high concentrations
reflect unacknowledged/undiagnosed respiratory disease,
nonrespiratory pathology resulting in increased NO excre-
tion through the respiratory tract, effects of air pollutants,
clinically benign genetic variants, or some other cause. As
clinical phenotypes are defined more fully in this ongoing
study, their associations with FeNO will be re-examined.
Effects of Growth
Previous studies of children have agreed that FeNO
increases with growth, but have disagreed concerning the
relative importance of age, height, and weight or body
mass index to this increase. These apparent inconsisten-
cies may reflect different age ranges and different clinical
exclusion criteria in different studies, as well as different
strategies for statistical modeling with multiple positively
correlated predictor variables. Our cross-sectional analysis
of a population with a narrow age range has limited abil-
ity to detect growth effects. Nevertheless, we have shown
a highly significant age-related increase beginning around
age 9, in general agreement with previous studies in North
America and Europe [23-26]. We found only a slight, non-
significant tendency to higher FeNO in taller versus
shorter subjects of the same age, but found a significant
tendency to lower FeNO in heavier-weight versus lighter-
weight subjects of a given height. This effect of weight (or
Percentile distributions of estimated online FeNO for  healthy, allergy-only, asthma-only, and allergy-plus-asthma  subjects Figure 1
Percentile distributions of estimated online FeNO 
for healthy, allergy-only, asthma-only, and allergy-
plus-asthma subjects. See Table 1 for number of subjects 
in each group. Allergy-only and allergy-plus-asthma groups 
are significantly (P < 0.0001) different from healthy group; 
asthma-only group is not significantly different.
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body mass index), if confirmed in other populations, may
have mechanistic implications, but seems too small to
impact the interpretation of clinical test results. Clearly,
however, changes in FeNO due to maturation must be
accounted for in some manner when interpreting FeNO
measurements in children. Our results suggest age as the
most appropriate adjustment factor, but they may not be
generalizable to younger or older children.
Ethnic Differences
We found higher adjusted mean FeNO in Hispanic chil-
dren than in non-Hispanic white children. To our knowl-
edge, this ethnic difference has not been reported
previously. Our observation of elevated FeNO in Asian-
descended boys, relative to European-descended boys and
Asian-descended girls, is consistent with previous findings
in Canada [24] and Hong Kong [29]. A genetic basis for
this phenomenon is possible, given that an environmen-
tal influence specific to Asian-descended boys, acting con-
sistently in all these locations, seems unlikely. Our results
do not entirely conform with the earlier findings, in that
we found little FeNO increase in Asian-American relative
to non-Hispanic white girls. Further studies with large
samples from both ethnic groups are needed to clarify the
gender-ethnicity interaction. Unfortunately, we did not
have a large enough sample of African-American children
to adequately examine difference from other groups. The
same was true in the Canadian study [23]. However, both
studies suggest that African-descended children fall below
Asian- and above European-descended children in their
range of FeNO. Similarly, in an earlier clinic-based multi-
national study of healthy children [25], non-Caucasian
(predominantly African-American) children showed a
borderline-significant increase in FeNO relative to Cauca-
sian children.
Validation of Methodology
We used an offline technique for measurement of FeNO.
We have reported elsewhere a strong correlation of offline
and online FeNO measurements in our study and have
developed a calibration equation to convert offline meas-
urement at 100 ml/s to the equivalent of online FeNO
measured at 50 ml/s [19,20]. We found a positive effect of
concurrent ambient NO concentration on FeNO that
could reflect contamination of collected breath samples
by ambient NO, and/or an acute biological response (e.g.
airway inflammation) to NO-containing ambient pollu-
tion, which might be expected on the basis of previous
findings in asthma panel studies [30,31]. From the on-
versus-offline comparison data, we concluded that the
association of offline FeNO with ambient NO in our sur-
veys is largely the result of a contamination artifact
[19,20]. Whatever the mechanism(s), short-term varia-
tions in ambient NO clearly can influence FeNO measure-
ments, and should be taken into account in analysis of
FeNO changes. Time-dependent changes in NO concen-
tration of stored breath samples may create additional
artifacts that should be accounted for, and samples must
be protected from exposure to outdoor light (and presum-
ably other strong light) during storage. With these caveats,
offline FeNO measurement with delayed analysis appears
to be a valid and practical tool for large-scale respiratory
health surveys. Even so, direct online FeNO measurement
is preferable, as it allows immediate and objective docu-
mentation of test quality. Reasonably portable online NO
analyzers are now available and have been used success-
fully in large-scale surveys [23,24]. Although new devices
are available, delayed offline measurement may be more
practical in some circumstances. Even with careful online
testing, comparability of FeNO measurements across dif-
ferent studies is not assured, since different manufactur-
ers' analyzers may read breath NO differently even when
calibrated with the same standard gases [27,28]. This sug-
gests that other trace breath constituents may enhance or
suppress NO chemiluminescence, and act differently with
different reaction chamber designs. Whatever their cause,
these differences dictate caution in inter-study data com-
parisons.
Conclusion
This study has demonstrated the feasibility of large-scale
field surveys of FeNO using offline breath collection and
delayed laboratory analysis. In our population-based
study, children's FeNO varied by respiratory allergy,
asthma, ethnic origin (particularly in boys of Asian
descent), and increasing age, as has been previously
Estimated online FeNO by sex and ethnic group, adjusted for  clinical status, age, body size, and community effects Figure 2
Estimated online FeNO by sex and ethnic group, 
adjusted for clinical status, age, body size, and com-
munity effects. Bar indicates geometric mean, flag indicates 
upper 95% confidence limit of geometric mean. See Table 1 
for number of subjects in each group. Significant differences: 
Hispanic > white, P = 0.02; Asian > white, P < 0.0001; Asian 
boys > Asian girls, P < 0.0001.
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reported. An apparently new finding of elevated FeNO in
Hispanic children relative to non-Hispanic white children
warrants further investigation. The results reemphasize
that FeNO may depend importantly on host factors other
than respiratory health. These other sources of variation
may complicate the interpretation of clinical FeNO tests.
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